Investor · San Diego, CA

Charles M. Baum

Open Charles in the network graph →

Filings

3

SEC Form D

Connections

25

co-filers

Capital

$142.2M

across filings

Active

Aug 2023

to Aug 2024

Most-connected co-filers (25)

Valerie D. Odegard · Boston, MA2 shared Jeffrey D. Leiden · Boston, MA2 shared Jill D. Carroll · Boston, MA2 shared Carl D. Gordon · Boston, MA2 shared Gary D. Glick · Boston, MA2 shared John C. Gillam · Wilmington, DE1 shared Christopher Mayer · Mt Airy, MD1 shared Timothy D. Walbert · Boston, MA1 shared Ian M. Smith · Boston, MA1 shared Rafael J. Amado · San Diego, CA1 shared Kristin J. Yarema · San Diego, CA1 shared Brent J. Warner · San Diego, CA1 shared Marcea B. Lloyd · San Diego, CA1 shared Cynthia M. Collins · San Diego, CA1 shared Luke M. Corning · San Diego, CA1 shared Johanna M. Mylet · San Diego, CA1 shared Harry J. Leonhardt · San Diego, CA1 shared Mark Gergen · San Diego, CA1 shared Roger K. Coit · Walnut Creek, CA1 shared Adam Lilling · Marina Del Rey, CA1 shared John Schmid · Hartford, CT1 shared David Grant · Plano, TX1 shared Patrick L. Reilly · Walnut Creek, CA1 shared Lorence M. Kim · Boston, MA1 shared

Recent filings (3)

Odyssey Therapeutics, Inc.Aug 2024 · 24 co-filers$121.1M Odyssey Therapeutics, Inc.Aug 2024 · 24 co-filers$121.1M Poseida Therapeutics, Inc.Aug 2023 · 21 co-filers$25.0M Poseida Therapeutics, Inc.Aug 2023 · 21 co-filers$25.0M Odyssey Therapeutics, Inc.Oct 2022 · 11 co-filers$174.9M Odyssey Therapeutics, Inc.Oct 2022 · 11 co-filers$174.9M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Charles in the interactive graph →